Data Points
Spotlight on the NIH
Ken Kostel | Jul 4, 2004
The National Institutes of Health spent more than 90% of its $27.17 billion FY 2003 budget on grants to support R&D activities in the United States. This was spread among nearly 2,900 institutions and morethan 52,000 awards.- Ken KostelSources: National Institutes of Health, American Association for the Advancement of Science
Industry Snapshot
Ken Kostel | Jun 20, 2004
Applications and approvals for new molecular entities (NMEs) in the United States continue to fall ...... while it continues to dominate R&D spending and total pharmaceutical sales.- Ken Kostel
Biotech by the Numbers
Ken Kostel | Jun 6, 2004
- Ken Kostel
Biodefense: Challenges, Priorities, Threats
Ken Kostel | May 23, 2004
The portion of the US budget dedicated to biodefense spending has proved difficult to track since 2001. Expenditures are spread out among several agencies and are often combined with defense and pre-paredness initiatives for chemical or nuclear threats. The National Institute of Allergy and Infectious Diseases (NIAID), one of the few agencies with a biodefense line-item, has seen that part of its budget grow dramatically over the past several years. In addition, the nation's network of Biosafety
Anchor or Engine in Eastern Europe?
Ken Kostel | May 9, 2004
As the European Union inches towards its goal of spending 3% of the gross domestic product (GDP) on research and development, 10 new member states are set to join the EU in May that lag behind the rest of Europe in spending by a wide margin. Where some see an impediment to growth, others believe the untapped potential of Eastern Europe may be crucial to the EU's ability to compete globally in knowledge-based industries.- Ken Kostel
Full Speed Ahead
Francesco Fiondella | Apr 25, 2004
Moved to LearnFrancesco FiondellaThe number of foreign students enrolled in EU colleges and universities in 1999In OverdriveAverage annual real growth of seed and start-up venture capital investment, 1995 to 2001
Not Yet a Biotech Empire
Francesco Fiondella | Apr 11, 2004
In the pipelineNumber of drugs in development by New York companiesEmploymentNumber of biotechnology employees in New York††Includes only those companies still in existence or operating in the state in 2002Facts and figures• New York is home to 101 biotechnology companies, more than half of which focus on the development of new therapeutic products and related drug-delivery technologies• For every public biotech company in New York state, there are about three private one
The (Garden) State of Life Sciences
Francesco Fiondella | Apr 11, 2004
Facts and figures• Employment: Compounded annual growth rate was 1.0% between 1990 and 2000-below the national average of 2.0%• Patents: 11.2 per 10,000 workers in 2000-above the national average of 7.5-but growth rate in the 1990s was 2.5% compared to 4.1% for the nation• Venture capital: Funding in 2002 was $106 per worker, slightly lower than the national average of $125• Fast-growth firms: NJ averaged 3.9% of all Inc500 fastest-growing firms between 1993–2002, c
Budgeting for Health
Francesco Fiondella | Mar 28, 2004
Power fiveFrancesco FiondellaThe five biggest institutes command more than half of the NIH's total funding:Next in rankThe next largest agencies still boast billion-dollar budgets:On the tail endThe remaining divisions of the NIH account for about a fifth of its total budget. A snapshot of some:Sources: Labor-HHS bill (HR 2660); NIH Office of Budget- Francesco Fiondella
Cancer Spotlight
Francesco Fiondella | Mar 14, 2004
UNITED STATESCompiled by Francesco FiondellaThe National Institutes of Health is the biggest funder of cancer research in the US. Figures include grants, contracts and intramural research.UNITED KINGDOMThe National Cancer Research Institute tracks funding given out by the UK's major cancer centers. Below, research spending in 2002.††Projects ongoing on April 2002 (most recent data available). Figures exclude overhead, marketing, etc.NOTE: Fiscal years used throughout. Figures for Bri
Innovation's Rewards
Francesco Fiondella | Mar 1, 2004
Patent PowerhousesCompiled by Francesco FiondellaInstitutions that received the most license income in fiscal-year 2002Banking on InventionInstitutions which got back the highest percentage of their research spending as license income in fiscal-year 2002. Pies are proportional to the institution's research expenditures.Science by the People, for the PeopleResearch expenditures for US universities, hospitals, and institutes equaled $37 billion in fiscal year 2002; most of the money came from fede
Postdoctoral Prospects
The Scientist Staff | Feb 15, 2004
National Science FoundationCompiled by Francesco FiondellaPostdoctoral support on NSF research grants, in millions of dollarsUK Research CouncilsTotal amount of postdoctoral fellowships given by the MRC, in millions of pounds†† Includes funding for both clinical and basic researchGrants given to postdocs by the BBSRC, in millions of pounds††††Not all disciplines shownNote: One British pound equalled $1.82 on Jan. 29Sources: National Science Foundation; Medical
Biotech Specs
The Scientist Staff | Feb 1, 2004
Test image - this needs to be removedTest image 3 - this needs to be removedTest image 4 - this needs to be removed
What's Up, Doc?
The Scientist Staff | Jan 18, 2004
Results from the latest survey of science doctorates earned in the United States
Foreign Ownership in U.S. Biotechs
The Scientist Staff | Dec 14, 2003
Data Points | Foreign Ownership in U.S. Biotechs Click for larger version of graph (25K) function sendData() { document.frm.pathName.value = location.pathname; result = false if (document.frm.score[0].checked) result = true; if (document.frm.score[1].checked) result = true; if (document.frm.score[2].checked) result = true; if (document.frm.score[3].checked) result = true; if (document.frm.score[4].checked) result = true; if (!result) alert("Please select") return result; }
Killer Diseases Through Time
The Scientist Staff | Jun 1, 2003
Datapoints | Killer Diseases Through Time Historic Pandemics Cases Deaths Justinian Plague, 6th Century China Plague (Bubonic) *142 million -100 million "Third Pandemic" 1896-1930 30 million 12 million Spanish Flu Pandemic 1918-1919 1 billion 21 million Sources: WHO, CDC *Based on estimated historic mortality rate of 70%   Pandemics Today       Per Year Per Year Malaria 300-500 million 1 million Tuberculosis 8 million 2 million AIDS 6
US Salaries -- Highs and Lows
The Scientist Staff | Jun 1, 2003
Datapoints | US Salaries -- Highs and Lows States with the Highest Median Life Sciences Salaries District of Columbia $80,000 New Jersey $75,000 Massachusetts $70,000 Delaware $68,230 California $67,960   States with the Lowest Median Life Sciences Salaries Montana $40,000 Wyoming $40,380 Kentucky $45,000 Hawaii $45,500 Rhode Island $46,000 Source: Abbott, Langer & Associates Note: These statistics are provided as an overview and not a definitive stud
Patenting DNA; Increased Recognition
The Scientist Staff | May 4, 2003
Datapoints Patenting DNA In 1976, the earliest year that patent records can be easily searched, six patents contained the term DNA. Things have changed since then. Year Number of patents with DNA in their abstracts 1988 147 1998 1,464 2002 1,040 Jan-Feb 2003 148 Source: US Patent Office (   Increased Recognition Number of LexisNexis citations on selected potential bioterrorism agents Month Smallpox Ricin Anthrax Aug. 2000 147 2 387 Sept. 2000 249 9 377 Aug. 2
Research Integrity
The Scientist Staff | Apr 6, 2003
Datapoints | Research Integrity The US Department of Health and Human Services' Office of Research Integrity oversees investigations of research misconduct related to US Public Health Service applications and awards.
Life Science Sojourners
The Scientist Staff | Mar 9, 2003
Data Points | Life Science Sojourners Biology and Agriculture PhD graduates in the US; selected countries of origin (1996) Taiwan -- 223 India -- 191 Korea -- 159 Mexico -- 51 Germany -- 42 United Kingdom -- 27 France -- 25 Greece -- 13 Italy -- 11